ARCHIVES

FDA’s New Guideline Proposal Meets More NCI Objections

This article is from The Cancer Letter archive.

Vol. 02 No. 12 | March 19, 1976

Download PDF Visit The Full Archive

Related Articles

Pitt Criticizes NCI Stance On Repayment For Fraud Trials

September 9, 1994

Drug Shortages Prompt Doctors, Societies to Consider Non-Profit Pharma Company

September 9, 2011

Concepts Approved for Primary Care, Worker Health, Black Interventions

May 17, 1985

Bush Nominates Health Policy Advisor McClellan For FDA Commissioner

September 27, 2002

NCI Announces New CREG Offer For In Vitro Chemical Carcinogenesis Tests

November 21, 1975

Georgetown Sponsors Oncology Agent Development Meeting

March 21, 2003